These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11739819)

  • 21. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI.
    Marks MP; Tong DC; Beaulieu C; Albers GW; de Crespigny A; Moseley ME
    Neurology; 1999 Jun; 52(9):1792-8. PubMed ID: 10371525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke.
    Alsop DC; Makovetskaya E; Kumar S; Selim M; Schlaug G
    Stroke; 2005 Apr; 36(4):746-50. PubMed ID: 15746457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early magnetic resonance imaging prediction of arterial recanalization and late infarct volume in acute carotid artery stroke.
    Hermier M; Nighoghossian N; Adeleine P; Berthezène Y; Derex L; Yilmaz H; Dugor JF; Dardel P; Cotton F; Philippeau F; Trouillas P; Froment JC
    J Cereb Blood Flow Metab; 2003 Feb; 23(2):240-8. PubMed ID: 12571455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance prediction of outcome after thrombolytic treatment.
    Pillekamp F; Grüne M; Brinker G; Franke C; Uhlenküken U; Hoehn M; Hossmann K
    Magn Reson Imaging; 2001 Feb; 19(2):143-52. PubMed ID: 11358651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging.
    Bardutzky J; Shen Q; Henninger N; Schwab S; Duong TQ; Fisher M
    Stroke; 2007 Apr; 38(4):1336-44. PubMed ID: 17322082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Diffusion Lesion Volume Above 70 mL Preclude Favorable Outcome Despite Post-Thrombolysis Recanalization?
    Tisserand M; Turc G; Charron S; Legrand L; Edjlali M; Seners P; Roca P; Lion S; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
    Stroke; 2016 Apr; 47(4):1005-11. PubMed ID: 26979862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage.
    Kidwell CS; Saver JL; Mattiello J; Warach S; Liebeskind DS; Starkman S; Vespa PM; Villablanca JP; Martin NA; Frazee J; Alger JR
    Neurology; 2001 Nov; 57(9):1611-7. PubMed ID: 11706101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.
    Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA
    J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
    J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biphasic neurovascular changes in prolonged migraine aura in familial hemiplegic migraine type 2.
    Iizuka T; Tominaga N; Kaneko J; Sato M; Akutsu T; Hamada J; Sakai F; Nishiyama K
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):344-53. PubMed ID: 25411546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and tissue response to intravenous thrombolysis in tandem internal carotid artery/middle cerebral artery occlusion: an MRI study.
    Thomalla G; Kruetzelmann A; Siemonsen S; Gerloff C; Rosenkranz M; Röther J; Fiehler J
    Stroke; 2008 May; 39(5):1616-8. PubMed ID: 18323483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brainstem hyperperfusion syndrome after intravenous thrombolysis: a case report.
    Lau CI; Lien LM; Chen WH
    J Neuroimaging; 2011 Jul; 21(3):277-9. PubMed ID: 20331500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of brain lesions in relation to hyperperfusion from subacute to chronic stages after experimental subarachnoid hemorrhage: a multiparametric MRI study.
    Tiebosch IA; van den Bergh WM; Bouts MJ; Zwartbol R; van der Toorn A; Dijkhuizen RM
    Cerebrovasc Dis; 2013; 36(3):167-72. PubMed ID: 24135525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of tissue survival after middle cerebral artery occlusion based on changes in the apparent diffusion of water.
    Sakoh M; Ostergaard L; Gjedde A; Røhl L; Vestergaard-Poulsen P; Smith DF; Le Bihan D; Sakaki S; Gyldensted C
    J Neurosurg; 2001 Sep; 95(3):450-8. PubMed ID: 11565867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke.
    Qureshi AI
    Neurosurgery; 2002 Jun; 50(6):1405-14; discussion 1414-5. PubMed ID: 12015866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome.
    Eckert B; Kucinski T; Neumaier-Probst E; Fiehler J; Röther J; Zeumer H
    Cerebrovasc Dis; 2003; 15(4):258-63. PubMed ID: 12686789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-Arterial Therapy and Post-Treatment Infarct Volumes: Insights From the ESCAPE Randomized Controlled Trial.
    Al-Ajlan FS; Goyal M; Demchuk AM; Minhas P; Sabiq F; Assis Z; Willinsky R; Montanera WJ; Rempel JL; Shuaib A; Thornton J; Williams D; Roy D; Poppe AY; Jovin TG; Sapkota BL; Baxter BW; Krings T; Silver FL; Frei DF; Fanale C; Tampieri D; Teitelbaum J; Lum C; Dowlatshahi D; Shankar JJ; Barber PA; Hill MD; Menon BK;
    Stroke; 2016 Mar; 47(3):777-81. PubMed ID: 26892284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The application of fast multiparametric protocol MRI-based thrombolysis with rt-PA hyperacute cerebral infarction.
    Bai Q; Zhao Z; Li Y; Sui H; Xie X; Gong Y; Zhao X; Wang L; Xia W; Shen J; Lu L
    Neurol Res; 2008 May; 30(4):344-7. PubMed ID: 18544249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.